About the study
The MedTech industry is confronted with massively disrupted supply chains, limited availability of essential materials, promised delivery dates postponed or even completely suspended and raw material prices increasing strongly - this development has now reached absurd levels in especially scarce areas.
Various factors like the pandemic, the Ukraine war and the energy crisis are interacting in a particularly dramatic way.
400 MedTech companies from the DACH region were invited to participate in this study. The results of the survey provide a dramatic picture of the current situation. It may be challenging, but there are ways to stay ahead of the competition.
Get our industry study on MedTech now.
Fill out the form and receive our MedTech study by email.